Search

Search Results
Results 101 - 109 of 109 for Anti-doping
  • Testavan
    Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Testavan intended for persons living in Australia.
  • Poppy seed brew triggers morphine overdose, drawing attention of lawmakers
    News - 9 Oct 2024
    It sounds like a joke: poppy seeds infused with opioids. Indeed, it was a plotline on the sitcom Seinfeld. But for some it has been a tragedy.
  • Effects on Antibiotic Resistance with Silver-Releasing Glass
    White Paper - 24 Jan 2020
    Antibiotic resistance is a significant problem, while silver, which can be delivered with silver-releasing glass could be a rediscovered solution.
  • A Thin-Film Microextraction Procedure for the Illicit Drug Screening of Biofluids
    Life Sciences - 11 Nov 2019
    A thin-film microextraction procedure for rapid and sensitive illicit drug screening of biofluids
  • Dapa-Tabs
    Drug - 10 Dec 2025
    Consumer Medicine Information (CMI) about Dapa-Tabs intended for persons living in Australia.
  • Androforte 5
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Androforte 5 intended for persons living in Australia.
  • Natrilix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Natrilix
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix (indapamide) intended for persons living in Australia.
  • Odaplix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Odaplix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback